Who
In numbers
- Trades disclosed
- 9
- Buys
- 3
- Sells
- 0
- Bought
- $57.7M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Jan 2023
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 21 Oct 2025filed 23 Oct 2025 | SMMT Summit TherapeuticsBiotechnology | SEC FORM 4 Bought | $10.0M533,617 at $18.74 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $50K5,438 at $9.18 | filing |
| 2 Jan 2024filed 4 Jan 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2024filed 4 Jan 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 7 Mar 2023filed 14 Feb 2024 | SMMT Summit TherapeuticsBiotechnology | SEC FORM 4 Bought | $22.6M21,523,530 at $1.05 | filing |
| 17 Jan 2023filed 14 Feb 2024 | SMMT Summit TherapeuticsBiotechnology | SEC FORM 4 Bought | $25.1M10,000,000 at $2.51 | filing |
News
No headline names them, or the companies they trade most, lately.